Humphreys Keith 4
4 · Indivior Pharmaceuticals, Inc. · Filed Jan 28, 2026
Research Summary
AI-generated summary of this filing
Indivior (INDV) Director Keith Humphreys Receives RSU Award
What Happened
- Keith Humphreys, a director of Indivior Pharmaceuticals, was granted 3,722 Restricted Stock Units (RSUs) on January 26, 2026. The grant shows a $0.00 acquisition price because RSUs are a contingent award that convert to common shares upon vesting; no cash was exchanged at grant.
Key Details
- Transaction date: 2026-01-26 (reported on Form 4 filed 2026-01-28). Transaction code: A (award/grant).
- Grant size and price: 3,722 RSUs @ $0.00 (total reported value $0).
- Vesting: Per footnote, each RSU represents the right to one share and vests the day immediately before the issuer's first annual meeting following the grant, subject to continued service.
- Shares owned after transaction: Not specified in the provided filing summary.
- No 10b5-1 plan, tax-withholding sale, or exercise noted in the filing.
Context
- RSU grants are a common form of equity compensation for directors and do not represent an immediate purchase or sale of stock; they provide future share delivery if vesting conditions are met. Such awards are routine compensation and should be viewed as part of governance/remuneration rather than an immediate market sentiment signal.
Insider Transaction Report
Form 4
Humphreys Keith
Director
Transactions
- Award
Common Stock
[F1]2026-01-26+3,722→ 9,524 total
Footnotes (1)
- [F1]Reflects a grant of Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest on the day immediately preceding the date of the first annual meeting of the Issuer's stockholders following the date of grant, subject to the Reporting Person's continued service to the Issuer on the vesting date.
Signature
/s/ Jordan Saltzberg, Power of Attorney|2026-01-28